Publications by authors named "Susan Geyer"

100Publications

One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.

J Clin Endocrinol Metab 2020 Aug 26. Epub 2020 Aug 26.

Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgaa592DOI Listing
August 2020

Phase I study of AR-42 and decitabine in acute myeloid leukemia.

Leuk Lymphoma 2020 Jun 8;61(6):1484-1492. Epub 2020 Feb 8.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1719095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375689PMC
June 2020

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.

Cancer Immunol Immunother 2019 Apr 6;68(4):619-629. Epub 2019 Feb 6.

Comprehensive Cancer Center, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, N924 Doan Hall 410 W. 10th Ave, Columbus, OH, 43210-1228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02308-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447692PMC
April 2019

Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables.

Diabetologia 2019 01 30;62(1):33-40. Epub 2018 Aug 30.

The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4722-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518395PMC
January 2019

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis.

JCI Insight 2018 08 9;3(15). Epub 2018 Aug 9.

Department of Medicine and the Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, Miami, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.120877DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129118PMC
August 2018

Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk.

Diabetologia 2018 09 21;61(9):2043-2053. Epub 2018 Jun 21.

Section of Diabetes and Endocrinology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, 6701 Fannin St, Suite 10.20, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4660-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611550PMC
September 2018

The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.

Pediatr Diabetes 2018 05 24;19(3):403-409. Epub 2017 Nov 24.

VA Puget Sound Health Care System; Division of Endocrinology, Metabolism and Nutrition, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pedi.12609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918232PMC
May 2018

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.

J Clin Oncol 2017 Oct 17;35(29):3315-3321. Epub 2017 Aug 17.

Maria E. Cabanillas and Komal Shah, The University of Texas MD Anderson Cancer Center, Houston, TX; Jonas A. de Souza, University of Chicago Medical Center, Chicago, IL; Susan Geyer, University of South Florida, Tampa; Michael E. Menefee, Mayo Clinic Jacksonville, Jacksonville, FL; Lori J. Wirth, Massachusetts General Hospital, Boston, MA; Stephen V. Liu, MedStar Georgetown University Hospital; John Wright, National Cancer Institute, Washington, DC; and Manisha H. Shah, Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.0226
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.0226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652872PMC
October 2017

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?

J Clin Endocrinol Metab 2017 08;102(8):2873-2880

Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Miami School of Medicine, Miami, Florida 33136.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-4003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546868PMC
August 2017

Late Effects of Exposure to Ionizing Radiation and Age on Human Thymus Morphology and Function.

Radiat Res 2017 05 20;187(5):589-598. Epub 2017 Mar 20.

b   Department of Pathology and the Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1667/RR4554.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505072PMC
May 2017

Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S181-S190.e4

The Comprehensive Cancer Center and The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH; Division of Hematology, The Ohio State University, Columbus, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999299PMC
August 2016

The Bayesian basket design for genomic variant-driven phase II trials.

Semin Oncol 2016 Feb 18;43(1):13-18. Epub 2016 Jan 18.

Department of Internal Medicine, The James Cancer Center, Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.01.002DOI Listing
February 2016

Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.

J Invest Dermatol 2015 Aug 25;135(8):2084-2092. Epub 2015 Mar 25.

Division of Dermatology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA; The Comprehensive Cancer Center and The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA; Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.116DOI Listing
August 2015

Human leukocyte antigen type and posttransplant lymphoproliferative disorder.

Transplantation 2015 Jun;99(6):1220-5

1 Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. 2 Division of Transplantation Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH. 3 Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. 4 The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000487DOI Listing
June 2015

Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.

Am J Clin Oncol 2016 12;39(6):614-618

*Department of Oncology, Oklahoma University, Oklahoma City, OK †Department of Internal Medicine, The Ohio State University, Columbus, OH ‡Department of Internal Medicine, University of California, San Francisco, CA §Mount Sinai School of Medicine, One Gustave Levy Place, New York ¶Roswell Park Cancer Institute, Buffalo, NY ∥1500 E Medical Center Dr, University of Michigan, Ann Arbor, MI #MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305484PMC
December 2016

Innate immune function predicts the development of nosocomial infection in critically injured children.

Shock 2014 Oct;42(4):313-21

*Pediatric Critical Care Medicine, Department of Pediatrics, and †The Research Institute, Nationwide Children's Hospital, Columbus, Ohio; ‡Critical Care Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio; §Department of Pathology, Nationwide Children's Hospital, Columbus, Ohio; and ║Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio; ¶Department of Neurological Surgery, University of California, San Francisco, San Francisco, California; and **Division of Hematology, The Ohio State University College of Medicine, Columbus; ††Emergency Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SHK.0000000000000217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167175PMC
October 2014

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

Blood 2014 Jun 2;123(24):3733-8. Epub 2014 Apr 2.

Department of Pathology, Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-12-547067DOI Listing
June 2014

A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma.

J Immunother 2014 Apr;37(3):180-6

*Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University, and Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, OH †Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966917PMC
April 2014

A phase II flexible screening design allowing for interim analysis and comparison with historical control.

Contemp Clin Trials 2013 Jul 22;35(2):128-37. Epub 2013 May 22.

Mayo Clinic and Mayo Foundation, Rochester, MN 55901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2013.05.007DOI Listing
July 2013

Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy.

Virchows Arch 2012 Oct 23;461(4):467-74. Epub 2012 Aug 23.

Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-012-1249-4DOI Listing
October 2012

The clinical spectrum of Castleman's disease.

Am J Hematol 2012 Nov 13;87(11):997-1002. Epub 2012 Jul 13.

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900496PMC
November 2012

Lifetime risk of stroke and impact of hypertension: estimates from the adult health study in Hiroshima and Nagasaki.

Hypertens Res 2011 May 17;34(5):649-54. Epub 2011 Feb 17.

Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/hr.2011.7DOI Listing
May 2011

Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia.

Cancer 2007 Jun;109(11):2291-8

Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22662DOI Listing
June 2007

Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.

Clin Cancer Res 2006 Oct;12(20 Pt 1):6056-63

Division of Hematology, Mayo Clinic, Rochester, Minnesota and North Central Cancer Treatment Group, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1245DOI Listing
October 2006